SOLV vs. PODD, TFX, SWAV, GMED, PEN, GKOS, INSP, HAE, MMSI, and BAX
Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include Insulet (PODD), Teleflex (TFX), Shockwave Medical (SWAV), Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), Inspire Medical Systems (INSP), Haemonetics (HAE), Merit Medical Systems (MMSI), and Baxter International (BAX). These companies are all part of the "surgical & medical instruments" industry.
Solventum (NYSE:SOLV) and Insulet (NASDAQ:PODD) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.
Insulet has higher revenue and earnings than Solventum.
In the previous week, Insulet had 30 more articles in the media than Solventum. MarketBeat recorded 45 mentions for Insulet and 15 mentions for Solventum. Insulet's average media sentiment score of 0.58 beat Solventum's score of 0.49 indicating that Insulet is being referred to more favorably in the news media.
Solventum presently has a consensus price target of $69.67, indicating a potential upside of 10.34%. Insulet has a consensus price target of $239.44, indicating a potential upside of 48.70%. Given Insulet's stronger consensus rating and higher probable upside, analysts clearly believe Insulet is more favorable than Solventum.
Insulet received 712 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 66.05% of users gave Insulet an outperform vote while only 0.00% of users gave Solventum an outperform vote.
Insulet has a net margin of 13.14% compared to Solventum's net margin of 0.00%. Insulet's return on equity of 34.06% beat Solventum's return on equity.
Summary
Insulet beats Solventum on 11 of the 11 factors compared between the two stocks.
Get Solventum News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solventum Competitors List
Related Companies and Tools
